Women's Health & STIs
Screening & Diagnostic Portfolio
For flexibility and performance based on clinical requirements
>1 Million STIs
are acquired every
day worldwide1
Chlamydia, Gonorrhoea,
Syphilis and Trichomoniasis
Are curable1
>75% of
Women
Experience at least one episode
of vaginitis/vaginosis
in their lifetime2
BD is committed to continued innovation to support you with an improved diagnostics portfolio, with efficient sample processing and accurate results
The BD MAX™ System, a fully automated, molecular platform providing rapid results for low to mid-volume testing needs
The BD MAX™ CT/GC and CT/GC/TV Assays for the direct detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis
The BD MAX™ Vaginal Panel for the detection of organisms associated with Bacterial Vaginosis, Candidiasis and Trichomoniasis
The BD COR™ System, a next generation fully automated platform for high-throughput screening of STIs and infectious disease*
Further assays are in development including a next-generation CT/GC/TV Assay with expanded claims, Mgen (Mycoplasma genitalium) and Vaginal Panel. Please contact a BD representative for more information.